BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants Jon Rousseau - Chairman, President & CEO Jennifer Phipps - CFO, Chief Accounting Officer & Principal Accounting Office Conference Call Participants David Deuchler - Gilmartin Group LLC Albert Rice - UBS Investment Bank, Research Division David Larsen - BTIG, LLC, Research Division Charles Rhyee - TD Cowen, Research Division Kieran Ryan - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Joanna Gajuk - BofA Securities, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Lawrence Solow - CJS Securities, Inc. Presentation Operator Good day, and thank you for standing by. Welcome to the BrightSpring Health Services Third Quarter 2025 Earnings Conference Call.
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.11 per share a year ago.
BrightSpring Health Services, Inc. (BTSG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BrightSpring Health Services, Inc. (BTSG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants David Deuchler - Corporate Participant Jennifer A. Phipps - CFO, Chief Accounting Officer & Principal Accounting Office Jon B.
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.1 per share a year ago.
BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how BrightSpring Health Services, Inc. (BTSG) and Incyte (INCY) have performed compared to their sector so far this year.
The heavy selling pressure might have exhausted for BrightSpring Health Services, Inc. (BTSG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.
BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.
BTSG faces margin pressure, but strong first-quarter gains in Pharmacy Solution and Provider Services lift confidence.